Nanomaterials In Personalized Medicine Market Forecast To Reach $674.28 Billion By 2030: Key Trends Explained
Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Nanomaterials In Personalized Medicine Market Value Growth And Long-Term Outlook
The market size for nanomaterials in personalized medicine has seen rapid expansion in recent years. It is projected to increase from $392.97 billion in 2025 to $438.79 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.7%. The historical growth of this market can be attributed to advancements in genomics and molecular biology, the growing adoption of targeted therapies, the expansion of translational medical research, the availability of advanced nanofabrication techniques, and the increase in academic-industry collaborations.
The market size for nanomaterials in personalized medicine is anticipated to experience substantial growth in the coming years. It is predicted to expand to $674.28 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 11.3%. This expansion during the forecast period is driven by factors such as the increasing demand for personalized healthcare solutions, rising investment in precision medicine programs, the broadening application of nanomaterials in diagnostics and imaging, a heightened focus on minimizing therapy side effects, and ongoing innovation in nano-enabled medical technologies. Key trends during this period include the increased use of targeted nanomaterials for individualized therapies, the growing integration of molecular diagnostics with nanotechnology, a rising adoption of nanomaterials in precision drug delivery, the expansion of nanotechnology into regenerative medicine, and an enhanced emphasis on patient-specific treatment outcomes.
Get A Free Sample Report With In-Depth Market Insights:
Nanomaterials In Personalized Medicine Market Growth Factors: What’s Supporting Expansion?
The rising demand for personalized medicine is anticipated to drive the expansion of the nanomaterials in personalized medicine market going forward. Personalized medicine is a medical approach that entails customizing treatments for individual patients based on their genetic, environmental, and lifestyle factors to maximize positive outcomes and enhance patient care. The demand for personalized medicine is growing owing to progress in genomic technologies, which facilitate accurate identification of genetic variations and tailored treatments for individuals. Nanomaterials in personalized medicine contribute to personalized medicine by supporting targeted and patient-specific therapies, leading to improved treatment effectiveness and safety. They permit the exact delivery of drugs, genes, or RNA, thereby lessening side effects and optimizing therapeutic results. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, a notable increase from the 12 approved in 2022. Consequently, the growing demand for personalized medicine is propelling the growth of the nanomaterials in personalized medicine market.
Nanomaterials In Personalized Medicine Market Breakdown By Product Type And Application
The nanomaterials in personalized medicine market covered in this report is segmented –
1) By Type Of Nanomaterials: Carbon-Based Nanomaterials, Metallic Nanoparticles, Polymeric Nanomaterials, Nanostructured Materials, Silica Nanoparticles
2) By Formulation Type: Nanoparticles, Nanosuspensions, Nanoemulsions, Nanocrystals, Nanoformulations For Targeted Delivery
3) By Technology Utilized: Nanofabrication Techniques, Bioconjugation Methods, Surface Modification Techniques, Molecular Imaging Techniques, Nanotechnology-Based Screening Methods
4) By Application Areas: Drug Delivery Systems, Diagnostics And Imaging, Therapeutics, Regenerative Medicine, Vaccines
5) By End-Users: Hospitals And Clinics, Research Laboratories, Pharmaceutical Companies, Biotechnology Firms, Academic Institutions
Subsegments:
1) By Carbon-Based Nanomaterials: Fullerenes, Carbon Nanotubes, Graphene, Carbon Dots
2) By Metallic Nanoparticles: Gold Nanoparticles, Silver Nanoparticles, Iron Oxide Nanoparticles, Copper Nanoparticles
3) By Polymeric Nanomaterials: Dendrimers, Micelles, Polymeric Nanoparticles, Hydrogels
4) By Nanostructured Materials: Quantum Dots, Nanowires, Nanosheets, Nanorods
5) By Silica Nanoparticles: Mesoporous Silica Nanoparticles, Colloidal Silica Nanoparticles, Porous Silica Nanoparticles, Functionalized Silica Nanoparticles
Nanomaterials In Personalized Medicine Market Industry Trends: What’s Reshaping Demand?
Leading companies in the nanomaterials in personalized medicine market are prioritizing strategic collaborations to expedite clinical translation, broaden therapeutic indications, and shorten time-to-market, all while conforming to evolving regulatory standards. These strategic collaborations represent partnerships where companies or institutions combine their expertise and resources to accelerate innovation and expand opportunities within personalized medicine. For example, in May 2025, Acuitas Therapeutics Inc., a Canada-based biotechnology company, joined forces with Integrated DNA Technologies Inc., a US-based genomics solutions provider. They launched a personalized CRISPR gene-editing therapy delivery system using their lipid nanoparticles platform, which was used to treat a single baby with a rare genetic disease. This treatment featured precisely targeted CRISPR payloads, bespoke dose tuning, and rapid custom formulation. This advancement accelerates the development of highly individualized, one-off treatments. While it enhances therapeutic precision and improves patient outcomes, it also introduces challenges related to scalable manufacture, stringent regulatory tailoring, and ultra-low-volume production.
Nanomaterials In Personalized Medicine Market Company Landscape And Competitive Strategy
Major companies operating in the nanomaterials in personalized medicine market are Pfizer & Co. Inc., BASF SE, Sanofi S.A., The Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Abbott Laboratories, Merck KGaA Darmstadt Germany, Evonik Industries AG, Eisai Co. Ltd., TÜV Rheinland AG, OCSiAl S.A., American Elements Inc., Cour Pharmaceuticals Inc., Nanocomposix Inc., NoPo Nanotechnologies Private Limited, Matexcel Biotech Inc., OncoNano Medicine Inc., Molecular Rebar Design Inc., Cello Therapeutics Inc., Apurano Pharmaceuticals GmbH, SGN Nanopharma Inc.
View The Full Nanomaterials In Personalized Medicine Market Report:
Nanomaterials In Personalized Medicine Market Regional Split: Which Areas Are Fueling Growth?
North America was the largest region in the nanomaterials in personalized medicine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the nanomaterials in personalized medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
